New User? Sign Up | Sign In

Insider Trading - MPM Oncology Impact Management GP LLC

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for MPM Oncology Impact Management GP LLC

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-11-02
Purchase
2017-11-06
9:27 pm
SUNESIS PHARMACEUTICALS INC SNSS MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
UBS Oncology Impact Fund L.P.
10% Owner
81,500 $2.773 $226,001 3,331,500
(Indirect)
View
2019-02-12
Purchase
2019-02-14
5:34 pm
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
250,000 $14 $3,500,000 3,898,422
(Direct)
View
2019-02-12
Sale
2019-02-14
5:34 pm
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
447 $14 $6,258 3,898,422
(Direct)
View
2019-02-19
Purchase
2019-02-21
6:06 pm
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
666,667 $15 $10,000,005 3,370,982
(Direct)
View
2020-07-28
Purchase
2020-07-30
08:00 am
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
320,000 $19 $6,080,000 2,355,557
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,525,165 $0 3,898,422
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,578,755 $0 3,898,422
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
417,853 $0 3,898,422
(Direct)
View
2019-02-12
Exercise
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
127,096 $0.0492 3,898,422
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,525,165 $0 3,898,422
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,578,755 $0 3,898,422
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
417,853 $0 3,898,422
(Direct)
View
2019-02-12
Exercise
2019-02-14
5:34 pm
2016-11-01
2026-11-01
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
76,258 $0.0492 3,898,422
(Direct)
View
2019-02-12
Exercise
2019-02-14
5:34 pm
2017-01-10
2027-01-10
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
50,838 $0.0492 3,898,422
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
2,421,775 $0 3,370,982
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
282,540 $0 3,370,982
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
15,000,000 $0 3,370,982
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,750,000 $0 3,370,982
(Direct)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,269,230 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
84,655 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
43,687 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
801,619 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
42,605 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
15,820 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,397,574 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
724,702 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
48,336 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
24,944 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
457,706 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
24,326 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
9,033 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
797,983 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
3,824,591 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
255,094 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
131,645 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,415,530 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
128,384 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
47,674 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
4,211,330 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,361,805 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
157,529 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
81,295 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,491,666 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
79,281 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
29,440 $0 2,355,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,600,628 $0 2,355,557
(Indirect)
View